[vc_row][vc_column width=”3/4″][vc_message]The global anticoagulants market is projected to register a CAGR of 8.42%, generating revenue of $66236.0 million by 2028. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2028. Anticoagulants are drugs that help prevent blood clots. These drugs are prescribed to individuals with a…
The Asia Pacific anticoagulants market is expected to witness growth with a CAGR of 8.83%, during the forecast period, 2021-2028. Request a Free Sample Report
[vc_row][vc_column width=”3/4″][vc_message]The Europe anticoagulants market is estimated to grow with a CAGR of 8.48%, during the forecast years of 2021 to 2028. The region’s market growth is primarily attributed to factors such as the increased prevalence of atrial fibrillation and venous thromboembolism (VTE), the rising healthcare expenditure, the surging obese and geriatric population, and the…
The North America anticoagulants market is expected to surge ahead with a CAGR of 8.16%, during the forecast period of 2021-2028. Request a Free Sample Report
[vc_row][vc_column width=”3/4″][vc_message]The India anticoagulants market is projected to register a CAGR of 9.72%, over the forecast years. The country’s market growth is mainly driven by factors such as the increased prevalence of chronic obstructive pulmonary disease (COPD), the high incidence of cardiovascular diseases (CVDs), and the introduction of newer oral anticoagulants (NOACs). The base year…